Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 16150699)

Published in J Biol Chem on September 02, 2005

Authors

Aiko Nakashima1, Takenobu Katagiri, Masato Tamura

Author Affiliations

1: Department of Biochemistry and Molecular Biology, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan.

Articles citing this

Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol (2007) 2.09

Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res (2010) 1.54

BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med (2008) 1.54

Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms. Cancer Res (2008) 1.34

BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells. Cell Death Differ (2010) 1.32

Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J Cell Sci (2009) 1.29

Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J Biol Chem (2010) 1.16

Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment. Neoplasia (2010) 1.06

Ethanol may suppress Wnt/beta-catenin signaling on human bone marrow stroma cells: a preliminary study. Clin Orthop Relat Res (2008) 1.03

Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc (2012) 1.01

Secreted frizzled related protein 1 is a target to improve fracture healing. J Cell Physiol (2009) 1.01

Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation. Lab Invest (2008) 0.96

Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene. J Biol Chem (2010) 0.96

Cytokine combination therapy prediction for bone remodeling in tissue engineering based on the intracellular signaling pathway. Biomaterials (2012) 0.95

Canonical Wnt signaling acts synergistically on BMP9-induced osteo/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). Biomaterials (2014) 0.94

Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm. BMC Genomics (2009) 0.94

Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis. Sci Rep (2014) 0.91

PDZRN3 negatively regulates BMP-2-induced osteoblast differentiation through inhibition of Wnt signaling. Mol Biol Cell (2010) 0.91

New insights on the roles of BMP signaling in bone-A review of recent mouse genetic studies. Biofactors (2011) 0.91

Integration of phosphatidylinositol 3-kinase, Akt kinase, and Smad signaling pathway in BMP-2-induced osterix expression. Calcif Tissue Int (2010) 0.90

Pannexin 3 inhibits proliferation of osteoprogenitor cells by regulating Wnt and p21 signaling. J Biol Chem (2013) 0.89

Canonical Wnt signaling induces BMP-4 to specify slow myofibrogenesis of fetal myoblasts. Skelet Muscle (2013) 0.87

Interaction of Wnt Signaling with BMP/Smad Signaling during the Transition from Cell Proliferation to Myogenic Differentiation in Mouse Myoblast-Derived Cells. Int J Cell Biol (2013) 0.87

Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells. J Periodontal Res (2011) 0.86

A specific role for phosphoinositide 3-kinase and AKT in osteoblasts? Front Endocrinol (Lausanne) (2012) 0.86

Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche. Blood (2009) 0.85

Bone morphogenetic protein 2-induced human dental pulp cell differentiation involves p38 mitogen-activated protein kinase-activated canonical WNT pathway. Int J Oral Sci (2015) 0.84

Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis. Cell Signal (2014) 0.83

Wnt signaling interacts with bmp and edn1 to regulate dorsal-ventral patterning and growth of the craniofacial skeleton. PLoS Genet (2014) 0.83

Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and 'in vivo' tracing with AAV vector serotype 6. Gene Ther (2012) 0.83

Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium. J Biol Chem (2011) 0.80

The Role of Bone Marrow Microenvironment in Governing the Balance between Osteoblastogenesis and Adipogenesis. Aging Dis (2015) 0.79

Nemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling. J Cell Biochem (2012) 0.79

Calcifying vascular smooth muscle cells and osteoblasts: independent cell types exhibiting extracellular matrix and biomineralization-related mimicries. BMC Genomics (2014) 0.78

Recombinant biglycan promotes bone morphogenetic protein-induced osteogenesis. J Dent Res (2014) 0.78

Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation. Arch Gynecol Obstet (2011) 0.75

Noncanonical Wnt signaling in stromal cells regulates B-lymphogenesis through interleukin-7 expression. Biochem Biophys Rep (2016) 0.75

Articles by these authors

Retracted DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol (2007) 4.45

BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med (2008) 4.20

PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps. Development (2002) 2.19

The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest (2009) 2.18

miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun (2008) 2.16

Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med (2009) 1.96

Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem (2008) 1.88

Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem (2003) 1.59

Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J Biol Chem (2005) 1.47

miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett (2009) 1.46

Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem (2006) 1.45

Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab (2008) 1.41

Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling. Mol Cell Biol (2011) 1.24

Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem (2009) 1.24

Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene. J Cell Biochem (2002) 1.22

Wnt signaling inhibits cementoblast differentiation and promotes proliferation. Bone (2009) 1.09

Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet (2010) 1.09

BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol Endocrinol (2011) 1.08

Bone morphogenetic protein-2 down-regulates miR-206 expression by blocking its maturation process. Biochem Biophys Res Commun (2009) 1.06

The PCR-Based Diagnosis of Central Nervous System Tuberculosis: Up to Date. Tuberc Res Treat (2012) 1.06

A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Biochem Biophys Res Commun (2008) 1.05

Purification and identification of a BMP-like factor from bovine serum. Biochem Biophys Res Commun (2006) 1.04

Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials (2006) 1.01

Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts. Immunology (2007) 0.98

Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J Biol Chem (2010) 0.98

Role of osteoglycin in the linkage between muscle and bone. J Biol Chem (2012) 0.98

A rare case of crowned dens syndrome mimicking aseptic meningitis. Case Rep Neurol (2013) 0.98

Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression. Genes Cells (2008) 0.96

Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: development and methodology. J Clin Microbiol (2008) 0.95

Deformity of the great toe in fibrodysplasia ossificans progressiva. J Orthop Sci (2010) 0.93

Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs. Biochem Biophys Res Commun (2007) 0.93

Acidic bone matrix proteins and their roles in calcification. Front Biosci (Landmark Ed) (2012) 0.93

Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism. Differentiation (2010) 0.93

Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. J Bone Miner Res (2010) 0.93

Carcinoid tumor of the renal pelvis: consideration on the histogenesis. Pathol Int (2008) 0.92

Quantitative nested real-time PCR assay for assessing the clinical course of tuberculous meningitis. J Neurol Sci (2007) 0.91

Invasive micropapillary carcinoma of the urinary bladder: an immunohistochemical study of neoplastic and stromal cells. Int J Urol (2006) 0.91

Early clinical and radiographic characteristics in fibrodysplasia ossificans progressiva: a report of two cases. J Bone Joint Surg Am (2011) 0.91

A novel mutation of ALK2, L196P, found in the most benign case of fibrodysplasia ossificans progressiva activates BMP-specific intracellular signaling equivalent to a typical mutation, R206H. Biochem Biophys Res Commun (2011) 0.90

Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. J Bone Miner Metab (2004) 0.88

Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase. Mol Endocrinol (2011) 0.88

Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes. J Bone Miner Metab (2012) 0.87

Establishment of a novel method for enriching osteoblast progenitors from adipose tissues using a difference in cell adhesive properties. Biochem Biophys Res Commun (2006) 0.87

Chromophobe renal cell carcinoma with prominent lymph node metastasis and polysomy of chromosome 21: poorly differentiated form or "presarcomatoid" form? Med Mol Morphol (2011) 0.87

Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway. J Bone Miner Metab (2008) 0.86

Identification and functional analysis of Zranb2 as a novel Smad-binding protein that suppresses BMP signaling. J Cell Biochem (2012) 0.86

Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation. Front Biosci (2006) 0.86

Modes of retrotransposition of long interspersed element-1 by environmental factors. Front Microbiol (2012) 0.85

Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: clinical application for diagnosis of tuberculous meningitis. J Clin Microbiol (2008) 0.85

Varicella zoster virus myelitis in two elderly patients: diagnostic value of nested polymerase chain reaction assay and antibody index for cerebrospinal fluid specimens. Case Rep Neurol (2013) 0.84

Enhanced cementum formation in experimentally induced cementum defects of the root surface with the application of recombinant basic fibroblast growth factor in collagen gel in vivo. J Periodontol (2004) 0.84

Pure hemi-chorea resulting from an acute phase of contralateral thalamic lacunar infarction: a case report. Case Rep Neurol (2012) 0.84

Effects of growth/differentiation factor-5 on human periodontal ligament cells. J Periodontal Res (2003) 0.84

Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1. Retrovirology (2013) 0.84

Involvement of retrotransposition of long interspersed nucleotide element-1 in skin tumorigenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate. Cancer Sci (2011) 0.84

Chromophobe renal cell carcinoma with neuroendocrine differentiation and sarcomatoid change. Pathol Int (2011) 0.83

Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Bone (2012) 0.83

Lactacystin, a proteasome inhibitor, enhances BMP-induced osteoblastic differentiation by increasing active Smads. Biochem Biophys Res Commun (2011) 0.83

Bisphosphonate-induced gastrointestinal mucosal injury is mediated by mitochondrial superoxide production and lipid peroxidation. J Clin Biochem Nutr (2012) 0.83

Establishment of cell lines that exhibit pluripotency from miniature swine periodontal ligaments. Arch Oral Biol (2007) 0.83

NSAIDs and acidic environment induce gastric mucosal cellular mitochondrial dysfunction. Digestion (2012) 0.83

Hepatocyte growth factor/scatter factor stimulates migration of muscle precursors in developing mouse tongue. J Cell Physiol (2004) 0.83

Wnt5a signaling is a substantial constituent in bone morphogenetic protein-2-mediated osteoblastogenesis. Biochem Biophys Res Commun (2012) 0.83

FGF23 induces expression of two isoforms of NAB2, which are corepressors of Egr-1. Biochem Biophys Res Commun (2006) 0.82

Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in aly/aly mice. Mol Endocrinol (2012) 0.82

Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice. J Bone Miner Metab (2012) 0.82

Chromosomal abnormalities of clear cell renal cell carcinoma: frequent gain of chromosome 7. Pathol Int (2010) 0.82

Inhibition of vascular endothelial growth factor expression by TRUE gene silencing. Biochem Biophys Res Commun (2009) 0.82

[Current advancement of the PCR-based molecular diagnosis for tuberculous meningitis]. Rinsho Shinkeigaku (2013) 0.82

DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts. Genes Cells (2009) 0.81

High-grade mucinous tubular and spindle cell carcinoma: comparative genomic hybridization study. Ann Diagn Pathol (2010) 0.81

TLE3, transducing-like enhancer of split 3, suppresses osteoblast differentiation of bone marrow stromal cells. Biochem Biophys Res Commun (2013) 0.80

The suppressive effect of enamel matrix derivative on osteocalcin gene expression of osteoblasts is neutralized by an antibody against TGF-beta. J Periodontol (2008) 0.80

Inhibition of BMP2-induced bone formation by the p65 subunit of NF-κB via an interaction with Smad4. Mol Endocrinol (2014) 0.80

Expanding the utility of heptamer-type sgRNA for TRUE gene silencing. Biochem Biophys Res Commun (2011) 0.80

Surface chemistry and biological responses to synthetic octacalcium phosphate. J Biomed Mater Res B Appl Biomater (2006) 0.79

[A case of acute autonomic, sensory and motor neuropathy (AASMN)--less favorable response of the autonomic dysfunctions to IVIg treatment]. Rinsho Shinkeigaku (2004) 0.79

Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials. Med Mol Morphol (2010) 0.79

Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels. Pathol Int (2009) 0.78

Pleiotrophin regulates bone morphogenetic protein (BMP)-induced ectopic osteogenesis. J Biochem (2002) 0.78

Elimination of specific miRNAs by naked 14-nt sgRNAs. PLoS One (2012) 0.78

Extracellular inorganic phosphate regulates gibbon ape leukemia virus receptor-2/phosphate transporter mRNA expression in rat bone marrow stromal cells. J Cell Physiol (2004) 0.78

The effect of enamel matrix derivative on spreading, proliferation, and differentiation of osteoblasts cultured on zirconia. Int J Oral Maxillofac Implants (2012) 0.78

Vascular cell-like potential of undifferentiated ligament fibroblasts to construct vascular cell-specific marker-positive blood vessel structures in a PI3K activation-dependent manner. J Vasc Res (2010) 0.78

FGFR3 down-regulates PTH/PTHrP receptor gene expression by mediating JAK/STAT signaling in chondrocytic cell line. J Electron Microsc (Tokyo) (2010) 0.78

Possible identification of third stromal component in extraadrenal paraganglioma: myofibroblast in fibrous band and capsule. Med Mol Morphol (2008) 0.78

High-grade urothelial carcinoma, plasmacytoid variant, of the renal pelvis with osteoclast-like giant cells and focal rhabdoid features. Pol J Pathol (2014) 0.77

Regulation of neuropeptide Y Y1 receptor expression by bone morphogenetic protein 2 in C2C12 myoblasts. Biochem Biophys Res Commun (2013) 0.77

Mutant activin-like kinase 2 in fibrodysplasia ossificans progressiva are activated via T203 by BMP type II receptors. Mol Endocrinol (2015) 0.77

Trichocyalides A and B, new inhibitors of alkaline phosphatase activity in bone morphogenetic protein-stimulated myoblasts, produced by Trichoderma sp. FKI-5513. J Antibiot (Tokyo) (2012) 0.77

A naked RNA heptamer targeting the human Bcl-2 mRNA induces apoptosis of HL60 leukemia cells. Cancer Lett (2012) 0.77

Renal cell carcinoma with extensive clear cell change sharing characteristics of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma. Pathol Int (2009) 0.77

Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells. Endocrine (2004) 0.76

Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib. Genes Cells (2012) 0.76

Enamel matrix derivative neutralized the effect of lipopolysaccharide on osteoprotegerin and receptor activator of nuclear factor kappa B ligand expression of osteoblasts. Arch Oral Biol (2009) 0.76

[A case of anaphylactoid shock occurring immediately after the initiation of second intravenous administration of high-dose immunoglobulin (IVIg) in a patient with Crow-Fukase syndrome]. Rinsho Shinkeigaku (2003) 0.76

Sarcomatoid acquired cystic disease-associated renal cell carcinoma. Histol Histopathol (2008) 0.76

Effect of dentin phosphoprotein on phosphate-induced apoptosis of odontoblast-like cells. Cells Tissues Organs (2008) 0.76

Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells. Bone (2012) 0.76